JB Chemical compounds block deal! KKR to probably promote as much as 10.2% stake value Rs 2,578 crore: Report

KKR & Co unit Tau Funding Holdings is anticipated to promote 6.8% fairness stake in JB Chemical compounds and Prescribed drugs through secondary share sale, ET Now reported, citing a time period sheet seen by it. The provide worth for the deal is Rs 1,625 per share which is at a reduction of 4.12% over at this time’s closing worth of Rs 1,695 on the NSE.

The inventory ended with a decline of Rs 35.40 or 2.05% over the Tuesday closing worth.

There can even be an oversubscription possibility of 5.3 million shares or 3.4% of fairness, the report stated. The overall stake sale might be as a lot as 10.2% or 10.6 million, together with oversubscription possibility.

The transaction worth is estimated at Rs 1,717.4 crore ($200 million) for the 6.8% holding, the report stated.

The E-book Working Lead Managers (BRLMs) are Kotak Securities, Jefferies, IIFL Capital, Spark (adviser).

The worth of greenshoe to retain oversubscription is Rs 861 crore or $100 million.JB Chemical compounds is a pharmaceutical firm which boasts of assorted merchandise and dosage kinds throughout therapeutic classes. It affords merchandise associated to gastroenterology, hypertension, and dermatology and has additionally entered newer therapeutic classes like nephrology, respiratory, virology, diabetes, and Nicotine Alternative Remedy (NRT).Shares of JB Chemical compounds have adopted a dropping pattern in 2025 up to now, declining by almost 10%. Its one-year returns stand at 5%.

The inventory is at the moment buying and selling under its 200-day easy transferring common of Rs 1,801 whereas managing to stay above its 50-day SMA of Rs 1,669.

(Disclaimer: Suggestions, strategies, views and opinions given by the consultants are their very own. These don’t symbolize the views of Financial Instances)